These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2677516)

  • 1. Plasma cholesterol, lipid lowering, and risk for cancer. An update of the results from epidemiologic studies and intervention trials.
    Lackner KJ; Schettler G; Kübler W
    Klin Wochenschr; 1989 Sep; 67(18):957-62. PubMed ID: 2677516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cholesterol-lowering treatment on coronary heart disease morbidity and mortality: the evidence from trials, and beyond.
    Katan MB
    Cardiology; 1990; 77 Suppl 4():8-13. PubMed ID: 2073675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease].
    Jost S; Lichtlen PR
    Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of lowering serum cholesterol.
    Verschuren WM
    Epidemiology; 1997 Mar; 8(2):120-2. PubMed ID: 9229199
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of hypercholesterolemia in the elderly].
    Alcântara P; Bicho M; Clara JG
    Rev Port Cardiol; 1992; 11(7-8):685-90. PubMed ID: 1389308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
    JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholesterol non-consensus in primary prevention of coronary heart disease. Methodologic problems in the interpretation of epidemiologic studies].
    Berger M
    Z Kardiol; 1993 Jul; 82(7):399-405. PubMed ID: 8379238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
    Ansell BJ; Watson KE; Fogelman AM
    JAMA; 1999 Dec; 282(21):2051-7. PubMed ID: 10591388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol lowering and mortality: the importance of considering initial level of risk.
    Smith GD; Song F; Sheldon TA
    BMJ; 1993 May; 306(6889):1367-73. PubMed ID: 8518602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoproteins and cholesterol: biosynthesis and metabolism.
    Weis SE
    J Am Osteopath Assoc; 1988 Jul; 88(7):870-6. PubMed ID: 3063699
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercholesterolemia in the United States: how far have we come?
    Brown WV
    Am J Med; 1997 Feb; 102(2A):3-6. PubMed ID: 9217579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey.
    Reiner Ž; De Bacquer D; Kotseva K; Prugger C; De Backer G; Wood D;
    Atherosclerosis; 2013 Dec; 231(2):300-7. PubMed ID: 24267243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of lipid-lowering clinical trials in relation to observational epidemiologic studies.
    Tyroler HA
    Circulation; 1987 Sep; 76(3):515-22. PubMed ID: 3304704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet and coronary heart disease.
    Stamler J
    Biometrics; 1982 Mar; 38 Suppl():95-118. PubMed ID: 7046825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperlipidemia and coronary heart disease].
    Schützenberger W; Harringer W; Leisch F
    Wien Med Wochenschr Suppl; 1989; 105():7-9. PubMed ID: 2694630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholesterol. Statements of the meeting on cholesterol, The Norwegian Medical Association, Oslo 10-12 October 1989].
    Tidsskr Nor Laegeforen; 1989 Nov; 109(33):3452-6. PubMed ID: 2609312
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.